Shenzhen Salubris Pharmaceuticals Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 1,535.785 million compared to CNY 2,356.019 million a year ago. Operating income was CNY 233.681 million compared to CNY 734.400 million a year ago. Net income was CNY 196.620 million compared to CNY 632.563 million a year ago. Basic earnings per share from continuing operations was CNY 0.19 compared to CNY 0.6 a year ago.